Filtered By:
Vaccination: Influenza Vaccine

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 6499 results found since Jan 2013.

What Organisms Cause Acute Epiglottitis in the Post- H. influenza Vaccination Era?
Discussion Epiglottitis is also known as supraglottitis and is caused by inflammation of the supraglottic structures and epiglottis. Usually the cause is infectious but other trauma such as thermal injuries or ingestions can also cause the disease. Before the widespread use of its conjugated immunization, Haemophilus influenza type b was the most common cause and it was usually thought of as a pediatric disease process. In the pre-immunization time period, acute epiglottitis in children was 3.47-6.0 cases per 100,000, and in the post-immunization period has declined to 0.3-0.7 cases per 100,000. However it appears that
Source: PediatricEducation.org - October 7, 2013 Category: Pediatrics Authors: Donna M. D'Alessandro, M.D. Tags: Uncategorized Source Type: news

Influenza vaccines in immunosuppressed adults with cancer.
CONCLUSIONS: Observational data suggests a lower mortality with influenza vaccination. Infection-related outcomes were lower or similar with influenza vaccination. The strength of evidence is limited by the small number of studies and by the fact that only one was a RCT. Influenza vaccination is safe and the evidence, although weak, is in favour of vaccinating adults with cancer receiving chemotherapy. PMID: 24166741 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - November 2, 2013 Category: Journals (General) Authors: Eliakim-Raz N, Vinograd I, Zalmanovici Trestioreanu A, Leibovici L, Paul M Tags: Cochrane Database Syst Rev Source Type: research

Influenza outbreak control practices and the effectiveness of interventions in long‐term care facilities: a systematic review
ConclusionsOur results indicate pharmaceutical control measures have the clearest reported protective effect in LTCFs. Non‐pharmaceutical approaches may be useful; however, most data were from observational studies and standardized reporting or well‐conducted clinical trials of NPI are needed to more precisely measure these effects.
Source: Influenza and Other Respiratory Viruses - November 7, 2013 Category: Infectious Diseases Authors: Kaitlin Rainwater‐Lovett, Kevin Chun, Justin Lessler Tags: Original Article Source Type: research

Experts with links to drugs industry 'hyped swine flu'
Conclusion This was a well-conducted study, albeit based on a small sample of articles. The finding that academics with ties to the drugs industry were more likely to make a higher assessment of risk from swine flu, and those promoting the use of antiviral drugs were more likely to have industry links, is worrying. The general issue of academics with undisclosed links to the pharmaceutical industry being interviewed by journalists is of concern. That said, the study does not prove that media coverage either fuelled public anxiety about swine flu or the policy decisions made about drug or vaccine funding. Similarly, the...
Source: NHS News Feed - November 12, 2013 Category: Consumer Health News Tags: Medical practice Medication Swine flu Source Type: news

What Organisms Cause Acute Epiglottitis in the Post- H. influenza Vaccination Era?
Discussion Epiglottitis is also known as supraglottitis and is caused by inflammation of the supraglottic structures and epiglottis. Usually the cause is infectious but other trauma such as thermal injuries or ingestions can also cause the disease. Before the widespread use of its conjugated immunization, Haemophilus influenza type b was the most common cause and it was usually thought of as a pediatric disease process. In the pre-immunization time period, acute epiglottitis in children was 3.47-6.0 cases per 100,000, and in the post-immunization period has declined to 0.3-0.7 cases per 100,000. However it appears that <...
Source: PediatricEducation.org - October 7, 2013 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Apocalypse maybe?
I can't remember the guy's name and I can't figure out a way to use your favorite on-line search engine to track it down, but many suns ago -- 20 years or so -- he was a highly controversial microbiologist who claimed it was a certainty -- not if but when -- that the global human population would be decimated by a global pandemic, or maybe several, of emerging infectious diseases.The controversy was not so much over whether this was true -- a lot of people in the public health field, of various disciplines, tended to think so. The controversy was because he gave the impression he thought this would be a good thing. The hum...
Source: Stayin' Alive - December 10, 2013 Category: Health Medicine and Bioethics Commentators Source Type: blogs

Do You Believe More Vaccines or Better Nutrition Prevents Disease?
Conclusion Tremendous government financial and medical resources are wasted on the development of more vaccinations to prevent diseases. No research has proven the effectiveness of vaccinations in preventing illness. Overwhelming evidence exists to show vaccines are dangerous to health and contribute to illness, injury and death. To prevent disease, one should avoid vaccinations, mercury dental fillings and toxic food. Following a nutrient-dense diet of whole, organic foods and removing toxic metals from the body are the best avenues to try and prevent illness and enhance health. References http://www.fierce...
Source: vactruth.com - December 20, 2013 Category: Health Medicine and Bioethics Commentators Authors: Michelle Goldstein Tags: Michelle Goldstein Top Stories Dr. Russell Blaylock National Institutes of Health (NIH) Nutrition truth about vaccines Weston Price Source Type: blogs

Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.
Abstract Yearly immunization against seasonal influenza is highly recommended for HIV-1 infected individuals but evaluating the success of vaccination by serological markers may not be fully informative in this population. Recently, it has been hypothesized that the generation of long-lasting immune responses may depend on whether similar antigens challenge the immune system frequently and intermittently. In the present study, in order to search for additional correlates of vaccine-induced protective immunity and to further dissect this theory, both humoral and memory B-cell responses to the trivalent 2012-2013 se...
Source: Vaccine - December 12, 2013 Category: Allergy & Immunology Authors: Rinaldi S, Zangari P, Cotugno N, Manno EC, Brolatti N, Castrucci MR, Donatelli I, Rossi P, Palma P, Cagigi A Tags: Vaccine Source Type: research

MenHibrix: A New Combination Meningococcal Vaccine for Infants and Toddlers.
CONCLUSIONS: Hib-MenCY-TT has been demonstrated to be a safe and immunogenic vaccination for prevention of disease caused by N meningitidis serogroups C and Y and H influenzae type b in healthy infants and toddlers. Currently, the ACIP recommends the use of Hib-MenCY-TT specifically in high-risk infants aged 6 weeks to 18 months. Hib-MenCY-TT provides the first therapeutic option for vaccination of infants as young as 6 weeks of age who are at increased risk for meningococcal disease. PMID: 24353263 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - December 18, 2013 Category: Drugs & Pharmacology Authors: Hale SF, Camaione L, Lomaestro BM Tags: Ann Pharmacother Source Type: research

Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities: a systematic review.
CONCLUSIONS: Our results indicate pharmaceutical control measures have the clearest reported protective effect in LTCFs. Non-pharmaceutical approaches may be useful; however, most data were from observational studies and standardized reporting or well-conducted clinical trials of NPI are needed to more precisely measure these effects. PMID: 24373292 [PubMed - in process]
Source: Respiratory Care - January 1, 2014 Category: Respiratory Medicine Authors: Rainwater-Lovett K, Chun K, Lessler J Tags: Influenza Other Respir Viruses Source Type: research

Reducing hospital admissions from nursing homes: a systematic review
Conclusions: Overall, eleven interventions to reduce hospital admissions from nursing homes were identified. None of them were tested more than once and the quality of the evidence was low for every comparison. Still, several interventions had effects on reducing hospital admissions and may represent important aspects of nursing home care to reduce hospital admissions.
Source: BMC Health Services Research - January 24, 2014 Category: Journals (General) Authors: Birgitte GraverholtLouise ForsetlundGro Jamtvedt Source Type: research

Neurological events related to influenza A (H1N1) pdm09
ConclusionsFatal cases and severe, permanent, neurological sequelae were observed in the infection group only. Clinical outcome was more favorable in the post‐vaccination group. In this context, the relevance of an accurate neurological evaluation is demonstrated for all suspicious cases, as well as the need of an appropriate long‐term clinical and imaging follow‐up of infection and post‐vaccination events related to influenza A (H1N1) pdm09, to clearly estimate the magnitude of neurological complications leading to permanent disability.
Source: Influenza and Other Respiratory Viruses - January 1, 2014 Category: Infectious Diseases Authors: Graciela Cárdenas, José Luis Soto‐Hernández, Alexandra Díaz‐Alba, Yair Ugalde, Jorge Mérida‐Puga, Marcos Rosetti, Edda Sciutto Tags: Original Article Source Type: research

The link between genetic variation and variability in vaccine responses: Systematic review and meta-analyses.
Abstract Although immune response to vaccines can be influenced by several parameters, human genetic variations are thought to strongly influence the variability in vaccine responsiveness. Systematic reviews and meta-analyses are needed to clarify the genetic contribution to this variability, which may affect the efficacy of existing vaccines. We performed a systematic literature search to identify all studies describing the associations of allelic variants or single nucleotide polymorphisms in immune response genes with vaccine responses until July 2013. The studies fulfilling inclusion criteria were meta-analyze...
Source: Vaccine - February 7, 2014 Category: Allergy & Immunology Authors: Posteraro B, Pastorino R, Di Giannantonio P, Ianuale C, Amore R, Ricciardi W, Boccia S Tags: Vaccine Source Type: research

Methodological quality of systematic reviews on influenza vaccination.
CONCLUSIONS: Systematic reviews on influenza vaccination showed large differences regarding their methodological quality. Reviews conducted by the Cochrane collaboration were of higher quality than others. When using systematic reviews to guide the development of vaccination recommendations, the methodological quality of a review in addition to its content should be considered. PMID: 24513008 [PubMed - as supplied by publisher]
Source: Vaccine - February 7, 2014 Category: Allergy & Immunology Authors: Remschmidt C, Wichmann O, Harder T Tags: Vaccine Source Type: research

Breastfeeding after maternal immunisation during pregnancy: Providing immunological protection to the newborn: A review.
Abstract Vaccination during pregnancy results in an augmentation of disease specific maternal antibodies. Immunoglobulin G (IgG) is mainly transferred through the placenta during the third trimester of pregnancy, while secretory Immunoglobulin A (sIgA) is passed through breast milk. At birth, newborns are partially protected against infectious diseases by these antibodies. This review aims to provide an overview of the effect of vaccination during pregnancy on the immunological protection of the newborn by the presence of disease specific sIgA antibodies in breast milk and their possible protective function agains...
Source: Vaccine - February 12, 2014 Category: Allergy & Immunology Authors: Maertens K, De Schutter S, Braeckman T, Baerts L, Van Damme P, De Meester I, Leuridan E Tags: Vaccine Source Type: research